Mechanisms of cancer stem cell therapy

AA Samadani, A Keymoradzdeh, S Shams… - Clinica Chimica …, 2020 - Elsevier
Cancer stem cells (CSCs) are responsible for carcinogenesis and tumorigenesis and are
involved in drug and radiation resistance, metastasis, tumor relapse and initiation …

Antimicrobial peptides: a promising strategy for lung cancer drug discovery?

F Zandsalimi, S Talaei… - Expert Opinion on …, 2020 - Taylor & Francis
ABSTRACT Introduction Antimicrobial peptides (AMPs), also called host defense peptides
(HDPs), are identified in almost any form of life, which play an important role in innate …

[HTML][HTML] The MEK/ERK/miR-21 signaling is critical in osimertinib resistance in EGFR-mutant non-small cell lung cancer cells

WC Huang, VK Yadav, WH Cheng, CH Wang… - Cancers, 2021 - mdpi.com
Simple Summary Our study provided data that the inhibition of MEK/ERK signaling could
overcome Osimertinib resistance both in vitro and in vivo. Mechanistically, MEK inhibitor …

[HTML][HTML] Effective drug concentration and selectivity depends on fraction of primitive cells

JJ Lica, M Wieczór, GJ Grabe, M Heldt, M Jancz… - International journal of …, 2021 - mdpi.com
Poor efficiency of chemotherapeutics in the eradication of Cancer Stem Cells (CSCs) has
been driving the search for more active and specific compounds. In this work, we show how …

[HTML][HTML] The role of extracellular vesicles in non-small-cell lung cancer, the unknowns, and how new approach methodologies can support new knowledge generation …

S Mullen, D Movia - European Journal of Pharmaceutical Sciences, 2023 - Elsevier
Extracellular vesicles (EVs) are nanosized particles released from most human cell types
that contain a variety of cargos responsible for mediating cell-to-cell and organ-to-organ …

Tumor microenvironment of cancer stem cells: Perspectives on cancer stem cell targeting

Q Guo, Y Zhou, T Xie, Y Yuan, H Li, W Shi, L Zheng… - Genes & …, 2023 - Elsevier
There are few tumor cell subpopulations with stem cell characteristics in tumor tissue,
defined as cancer stem cells (CSCs) or cancer stem-like cells (CSLCs), which can …

[HTML][HTML] MET inhibitor, capmatinib overcomes osimertinib resistance via suppression of MET/Akt/snail signaling in non-small cell lung cancer and decreased …

K Zhu, Z Lv, J Xiong, H Zheng, S Zhang, H Jin… - Aging (Albany …, 2021 - ncbi.nlm.nih.gov
Background: Patients with non-small cell lung cancer (NSCLC) initially responding to
tyrosine kinase inhibitors (TKIs) eventually develop resistance due to accumulating …

[HTML][HTML] CD44+/EPCAM+ cells detect a subpopulation of ALDHhigh cells in human non-small cell lung cancer: A chance for targeting cancer stem cells?

V Masciale, G Grisendi, F Banchelli, R D'Amico… - Oncotarget, 2020 - ncbi.nlm.nih.gov
Objectives: Several studies demonstrated that aldehyde dehydrogenase (ALDH) and CD44
are the most considered cancer stem cells (CSC) markers. However, a comparison between …

[HTML][HTML] 5-O-Acetyl-Renieramycin T from Blue Sponge Xestospongia sp. Induces Lung Cancer Stem Cell Apoptosis

W Chantarawong, S Chamni, K Suwanborirux, N Saito… - Marine drugs, 2019 - mdpi.com
Lung cancer is one of the most significant cancers as it accounts for almost 1 in 5 cancer
deaths worldwide, with an increasing incident rate. Management of the cancer has been …

[HTML][HTML] The synergistic effect of piperlongumine and sanguinarine on the non-small lung cancer

M Hałas-Wiśniewska, W Zielińska, M Izdebska… - Molecules, 2020 - mdpi.com
Background: Cancers are one of the leading causes of deaths nowadays. The development
of new treatment schemes for oncological diseases is an interesting direction in …